Package 57237-159-05

Brand: repaglinide

Generic: repaglinide
NDC Package

Package Facts

Identity

Package NDC 57237-159-05
Digits Only 5723715905
Product NDC 57237-159
Product ID 57237-159_641cf1c4-6d24-4ad7-b85a-b2ddbb9263c4
Description

500 TABLET in 1 BOTTLE (57237-159-05)

Marketing

Marketing Status
Marketed Since 2014-01-22
Brand repaglinide
Generic repaglinide
Sample Package No

Linked Drug Pages (1)

Repaglinide ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "641cf1c4-6d24-4ad7-b85a-b2ddbb9263c4", "openfda": {"nui": ["N0000175428", "N0000175448"], "upc": ["0357237157015", "0357237158012", "0357237159019"], "unii": ["668Z8C33LU"], "rxcui": ["200256", "200257", "200258"], "spl_set_id": ["d7673e22-0dbb-4395-ad60-943d249203a1"], "pharm_class_epc": ["Glinide [EPC]"], "pharm_class_moa": ["Potassium Channel Antagonists [MoA]"], "manufacturer_name": ["Rising Pharma Holdings, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (57237-159-01)", "package_ndc": "57237-159-01", "marketing_start_date": "20140122"}, {"sample": false, "description": "500 TABLET in 1 BOTTLE (57237-159-05)", "package_ndc": "57237-159-05", "marketing_start_date": "20140122"}], "brand_name": "Repaglinide", "product_id": "57237-159_641cf1c4-6d24-4ad7-b85a-b2ddbb9263c4", "dosage_form": "TABLET", "pharm_class": ["Glinide [EPC]", "Potassium Channel Antagonists [MoA]"], "product_ndc": "57237-159", "generic_name": "Repaglinide", "labeler_name": "Rising Pharma Holdings, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Repaglinide", "active_ingredients": [{"name": "REPAGLINIDE", "strength": "2 mg/1"}], "application_number": "ANDA203820", "marketing_category": "ANDA", "marketing_start_date": "20140122", "listing_expiration_date": "20261231"}